ULBP2 and pancreatic neoplasm: Decrease of sULBP2 and increase of membrane-bound ULBP2 thus promote NK cells activation and may improve the antitumor effect against pancreatic cancer, which will be further confirmed by studies on tissues of pancreatic cancer patients.